Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Dec 27, 2024; 16(12): 3729-3736
Published online Dec 27, 2024. doi: 10.4240/wjgs.v16.i12.3729
Table 1 General information of three groups of patients
Data
Benign lesions (n = 135)
Precancerous lesions (n = 123)
Early GC (n = 127)
χ2/F value
P value
Sex, n (%)3.8190.148
Male75 (55.56)81 (65.85)70 (55.12)
Female60 (44.44)42 (34.15)57 (44.88)
Age (years), mean ± SD56.34 ± 8.0755.11 ± 7.2656.50 ± 8.801.6680.190
Body mass index (kg/m2), mean ± SD23.03 ± 3.3623.28 ± 3.0722.67 ± 3.361.1020.333
Family history of GC, n (%)0.6010.741
Without127 (94.07)116 (94.31)117 (92.13)
With8 (5.93)7 (5.69)10 (7.87)
History of smoking, n (%)2.4580.293
Without81 (60.00)62 (50.41)72 (56.69)
With54 (40.00)61 (49.59)55 (43.31)
History of drinking, n (%)2.4400.295
Without101 (74.81)85 (69.11)84 (66.14)
With34 (25.19)38 (30.89)43 (33.86)
Table 2 The value of pepsinogen ratio screening for precancerous lesions
Indicators
AUC
SE
95%CI
Cut-off value
Specificity (%)
Sensitivity (%)
PGR0.6110.0350.542-0.68034.1738.5296.75
H. pylori0.5820.0360.512-0.652/57.0459.35
Combined detection0.6890.0340.623-0.7540.5071.8566.67
Table 3 Value of pepsinogen ratio screening for early gastric cancer
Screening indicator
Indicators
AUC
SE
95%CI
Cut-off value
Specificity (%)
Sensitivity (%)
Precancerous lesions and early GCPGR0.6180.0360.547-0.69020.4836.5999.21
H. pylori0.5020.0370.430-0.573/59.3540.94
Combined detection0.6180.0360.547-0.6890.3998.4336.59
Benign lesions and early GCPGR0.7080.0320.644-0.77120.6850.3799.21
H. pylori0.5810.0350.511-0.650/57.0459.06
Combined detection0.7500.0300.690-0.8090.3844.4499.21